Proton pump inhibitors are a class of medications used to treat conditions like GERD and ulcers. They work by blocking the ...

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

Waystar upped its 2024 outlook and now expects total revenue to range between $926 million and $934 million, compared to ...

They keep costs low by prescribing generic versions of brand-name drugs, like Viagra and Cialis, that work just as well as ...

Hims & Hers Health, Inc. (NYSE:HIMS) investors will be delighted, with the company turning in some strong numbers with its latest results. It was overall a positive result, with revenues beating ...

Additionally, some under-the-weather employees will feel well enough to get some work done if they can do so from home. 5. Telecommuting eliminates unnecessary meetings. Most business owners ...

At-home careers and WFH jobs are more popular than ever before, with many companies supporting work-life balance. And FlexJobs is here to get you connected with a database full of legitimate work-from ...

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025. "We have already confirmed a core supplier ...

At this time, I would like to welcome everyone to Hims & Hers Third Quarter 2024 Earnings ... Standard doses will work for many patients, however, given the diversity of obesity challenges across ...

Hims & Hers Health, Inc. HIMS delivered an earnings per share (EPS) of 32 cents in third-quarter 2024 against the year-ago period’s loss of 4 cents per share. The metric was in line with the Zacks ...

Direct-to-consumer telehealth company Hims & Hers is defending its sale of compounded glucagon-like peptide agonists, or GLP-1s, even as shortages of the name brand weight loss medications are waning.